Two Sigma Investments
VIR icon

Two Sigma Investments’s Vir Biotechnology VIR Stock Holding History

Two Sigma Investments’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.3M Sell
1,110,227
-329,267
-23% -$3.13M 0.01% 1440
2026
Q1 		$12.9M Buy
1,439,494
+849,933
+144% +$6.77M 0.01% 1241
2025
Q4 		$3.56M Sell
589,561
-59,739
-9% -$356K 0.01% 2012
2025
Q3 		$3.71M Buy
649,300
+279,685
+76% +$1.43M 0.01% 1698
2025
Q2 		$1.86M Buy
369,615
+97,080
+36% +$520K ﹤0.01% 1884
2025
Q1 		$1.77M Buy
272,535
+26,659
+11% +$237K ﹤0.01% 1816
2024
Q4 		$1.8M Sell
245,876
-30,148
-11% -$238K ﹤0.01% 1791
2024
Q3 		$2.07M Sell
276,024
-80,521
-23% -$699K ﹤0.01% 1661
2024
Q2 		$3.17M Buy
356,545
+291,033
+444% +$2.79M 0.01% 1244
2024
Q1 		$664K Buy
65,512
+7,000
+12% +$71.3K ﹤0.01% 2199
2023
Q4 		$589K Buy
58,512
+36,912
+171% +$337K ﹤0.01% 2369
2023
Q3 		$202K Sell
21,600
-34,701
-62% -$495K ﹤0.01% 2638
2023
Q2 		$1.38M Buy
56,301
+15,314
+37% +$385K ﹤0.01% 1753
2023
Q1 		$954K Buy
40,987
+22,287
+119% +$570K ﹤0.01% 1890
2022
Q4 		$473K Buy
+18,700
New +$458K ﹤0.01% 2048
2021
Q3 		– Sell
-26,300
Closed -$1.24M – 4752
2021
Q2 		$1.24M Buy
+26,300
New +$1.2M ﹤0.01% 2290

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Two Sigma Investments's VIR Position: Q2 2026 in Review

Two Sigma Investments reduced its Vir Biotechnology (VIR) stake by 23% in Q2 2026, selling an estimated $3.13M and leaving 1,110,227 shares worth $11.3M. The position accounts for 0.01% of the portfolio, ranked #1440.

Two Sigma Investments first reported a position in VIR in Q2 2021 and has held it in 16 quarters since. The position peaked at $12.9M in Q1 2026. 238 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Two Sigma Investments held 1,110,227 shares of Vir Biotechnology worth $11.3M as of Q2 2026.
  • Two Sigma Investments sold 329,267 Vir Biotechnology shares in Q2 2026, an estimated $3.13M.
  • Vir Biotechnology made up 0.01% of Two Sigma Investments's portfolio in Q2 2026, its #1440 holding.
  • Two Sigma Investments first reported a position in Vir Biotechnology in Q2 2021 and has held it in 16 quarters since.
  • Two Sigma Investments's Vir Biotechnology position peaked at $12.9M in Q1 2026.
  • 238 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.